Results 261 to 270 of about 354,830 (305)
Some of the next articles are maybe not open access.

Anti-HIV drugs.

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 2007
There are, at present, 22 compounds which have been formally approved (by the US Food and Drug Administration) for the treatment of HIV infections (AIDS). According to their point of intervention with the HIV replicative cycle, these compounds can be classified in 5 categories: (1) NRTIs (nucleoside reverse transcriptase inhibitors): azidothymidine ...
openaire   +1 more source

Cervical cancer prevention and control in women living with human immunodeficiency virus

Ca-A Cancer Journal for Clinicians, 2021
Philip E Castle, Vikrant V Sahasrabuddhe
exaly  

[Anti-HIV drugs].

La Revue du praticien, 1999
Anti-HIV drugs act by blocking intracellular replication of the virus by inhibiting viral enzyme either reverse transcriptase or protease. Reverse transcriptase inhibitors belong to 3 different categories: nucleoside analogues, which active forms are the triphosphorylated intracellular compound, non nucleoside inhibitors and the more recent nucleotide ...
openaire   +1 more source

Anti-HIV therapy

AIDS, 2000
Anthony P Geraci, Alessandro Di Rocco
openaire   +1 more source

Anti-HIV

Current Bioactive Compounds, 2007
openaire   +1 more source

Anti-HIV dendrimeric peptides

2009
Qitao, Yu, Ling, Li, James P, Tam
openaire   +2 more sources

Anti-HIV Agents

2020
Bogdan Bumbăcilă, null Putz
openaire   +1 more source

Prolonged viral suppression with anti-HIV-1 antibody therapy

Nature, 2022
Christian Gaebler   +2 more
exaly  

Anti-HIV

Current Bioactive Compounds, 2005
openaire   +1 more source

Home - About - Disclaimer - Privacy